High Court To Hear Stryker Patent Case On Willful Infringement Standards
This article was originally published in The Gray Sheet
Executive Summary
The US Supreme Court will consider arguments on what standards should be met if an award in a patent violation case is to be increased due to willful infringement. A District Court judge tripled a $70 million award Stryker was granted against Zimmer for infringement in a jury trial, but the award was reduced on appeal.
You may also be interested in...
Stryker Asks High Court To Allow More Leeway In Awarding Triple Damages
The device firm's opening brief in a Supreme Court patent case says a two-part test for enhanced damages imposed by the Federal Circuit is unconstitutional and should be struck down in place of greater judge discretion.
News Briefs: FDA Turns Down Wright’s Augment; Cook Resumes Zilver PTX Shipments; Luminex Restructures
Wright Medical receives not approvable letter for its Augment bone graft asking for another study. Judge rules against Zimmer in favor of Strkyer in patent case. Cook Medical has resolved the problems that triggered a December 2012 recall of its Zilver PTX peripheral stent. Luminex cuts staff, invests in molecular diagnostics efforts.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”